BIS icon

ProShares UltraShort NASDAQ Biotechnology

7 hedge funds and large institutions have $2.94M invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1.49M 58,865 +50,863 +636%
Citadel Advisors
2
Citadel Advisors
Florida
$652K 25,806 -9,166 -26%
IMC Chicago
3
IMC Chicago
Illinois
$590K 23,335 +2,332 +11%
TRCT
4
Tower Research Capital (TRC)
New York
$205K 8,123 -823 -9%
Morgan Stanley
5
Morgan Stanley
New York
$3K 107 +31 +41%
Citigroup
6
Citigroup
New York
$2K 85
OMC
7
Old Mission Capital
Illinois
-15,311 Closed
UBS Group
8
UBS Group
Switzerland
$0 1 -401 -100%
CFGS
9
Concourse Financial Group Securities
Alabama